BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

benzinga.com/25/05/45205736/biontech-appoints-novartis-executive-as-finance-chief-reaffirms-2025-guidance-focuses-on-oncology-expansion

BioNTech SE (NASDAQ:BNTX) on Monday reported a first-quarter per-share loss of $1.82 (1.73 euros), up from 1.31 euros reported a year ago compared to beating the consensus of $2.02.
The COVID-19 vaccine maker reported sales of $192.23 million (182 million euros), compared to 187 million…

This story appeared on benzinga.com, 2025-05-05 19:49:24.
The Entire Business World on a Single Page. Free to Use →